BME
BlackRock Health Sciences Trust
43.30$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.8% | -9.1% | +22.3% | +6.2% | +386.5% | -67.9% | +17.0% | -6.6% | -1.7% | +29.9% | -26.4% | |
| – | +493.0% | -15.3% | -83.9% | +177.8% | +28.4% | -61.9% | -99.8% | +224.8% | -1,313.6% | – | -79.9% | |
| – | -73.2% | +17,132.4% | -99.5% | -70.0% | +173,967.0% | -57.8% | -99.5% | +224.8% | -82.9% | +13,259.4% | -99.2% | |
| – | +195,564.4% | +1.0% | +61.2% | +80.1% | -98.1% | -57.8% | -99.5% | +224.8% | -82.9% | +4,973,458.2% | -81.5% | |
| – | +539.6% | -24.7% | -81.9% | +177.8% | -31.4% | -34.6% | +746.0% | -25.5% | -33.4% | -24.2% | -64.2% | |
| – | -100.0% | – | – | – | – | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | -16.9% | -3.3% | +2.0% | +3,226.6% | -90.8% | +167.4% | -74.2% | +34.3% | -24.4% | -69.6% | |
| – | +0.1% | -16.9% | -3.3% | -66.3% | +63.8% | +466.6% | +44.9% | -98.1% | +3,311.3% | – | – | |
| – | – | – | +3.2% | -96.4% | +5,328.9% | -59.5% | +106.0% | -98.6% | +1,978.3% | -65.2% | – | |
| – | +196.2% | -4.5% | -100.0% | – | +63.8% | -92.5% | +10,828.5% | -98.1% | – | – | -57.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.8% | -9.0% | +22.6% | +6.3% | +363.9% | +84.8% | -79.3% | -4.1% | -2.0% | +30.7% | -26.1% | |
| – | -100.5% | – | -305.2% | – | +17.6% | +76.4% | +13.8% | -25.2% | -3.1% | -201.8% | – | |
| – | +5.3% | +5.2% | +2.8% | -2.1% | +1,195.6% | +0.0% | +0.2% | -88.8% | +10.6% | -4.9% | -1.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.